|Event Date||Sun Feb 16 EST - Tue Feb 18 EST (over 1 year ago)|
Seminole Hard Rock Hotel & Casino
1 Seminole Way, Fort Lauderdale, FL 33314, USA
Noble Capital Markets' Sixteenth Annual Emerging Growth Investor Conference
We’re more about limitation than expansion. 125 public companies is not a small number. Any more, however, will start limiting investors’ direct-access to the executive teams over the two-day agenda. We run four presentation tracks, no more. Any more and we would lose the camaraderie and intimacy we’ve strived to create over the last fifteen years. Don’t get us wrong. We think big in terms of the presenting company selection process, the experience-value of our networking events and the precision of the scheduling of 1500 meetings. Another expansion we’re excited about is broadening access to investors worldwide by hosting the conference site on Channelchek.com. Investors and the general public gain full access at no cost to the site devoted to increasing awareness for emerging growth companies. That’s pretty much the purpose of NobleCon. And while we’re still on the subject of big, for NC2020 we’re beaming all company presentations on 8’X12’ screens utilizing the newest technology - UHD laser projection. NobleCon16. Not too big, not too small. Just right.
Dr. Camillo Ricordi
Director of the Diabetes Research Institute, University of Miami School of Medicine
Dr. Matthias von Herrah, MD
Founder of the Type 1 Diabetes Center, La Jolla Institute for Immunology
Dr. Bastiano Sanna
President & COO of Semma Therapeutics
Dr. Steven Perrin
CEO, and co-Founder of Anelixis Therapeutics
Platinum-selling songwriter/performer, Owner, Apple Podcast Level With Me
Dr. James Mule
Associate Center Director, Moffitt Cancer Center / Member, Noble Scientific Advisory Board
Dr. Lauren Wood
Chief Medical Officer, PDS Biotechnology / Former Clinical Director, Vaccine Branch
Dr. Johannes Vieweg
Founding Dean & Chief Academic Officer, Nova Southeastern University
Dr. Herman Chao
CEO, Helix Biopharma
Co-Founder, Green Roads World
Managing Director, Phyto Partners, LP
Partner, Greenspoon Marder, LLP
Founder, The Leafy Group
Paul Ashton, PhD.
Co-Founder & CEO, Inflammasome Therapeutics, Inc.
Gary Glick, PhD.
Co-Founder & Executive Chairman, IFM Therapeutics and Michigan Professor of Chemistry
Co-Founder, President & CEO, Zyversa Therapeutics, Inc.
Robert W. Keane, PhD.
Professor Physiology & Biophysics, Neurological Surgery & Microbiology, and Immunology, University of Miami
Adam Keeney, PhD.
President & CEO, Nodthera, Ltd
Clay B. Thorp
General Partner, Hatteras Venture Partners
President, CEO, & Director, Ely Gold Royalties Inc.
VP, Corporate Development and Communications, Lumina Gold Corp.
CEO & Director, Newrange Gold Corp.
CEO & President, Sierra Metals
CEO, Eagle Bulk Shipping, Inc.
Jeffrey D. Pribor
CFO, Treasurer, International Seaways, Inc.
CEO, Pyxis Tankers
CFO, EuroDry and Euroseas
Cosme Ordonez, MD, PhD
Noble Capital Markets, Director of Life Sciences Research
Founder, Cannabis Labs
Senior Research Analyst, Noble Capital Markets
Senior Transportation & Logistics Analyst, Noble Capital Markets
• Noble Capital Markets
• Quote Media
• Greenberg Trauig
• Channel Chek
• Dickinson Wright PLLC